Viewing Study NCT02414750

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2026-02-20 @ 6:39 PM
Study NCT ID: NCT02414750
Status: TERMINATED
Last Update Posted: 2022-11-30
First Post: 2015-02-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Vemurafenib Plus Cobimetinib in Metastatic Melanoma
Sponsor: Netherlands Working Group on Immunotherapy of Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vemurafenib/cobimetinib (GDC-0973) View
None Melanoma View
None Positron Emission Tomography View
None Tumor Characteristics View
None Response monitoring View
None Resistance prediction View
None molecular targeted therapy View